Orthopedic Biomaterials Market Report Suite for US 2017-2023 - MedSuite (Includes 10 Reports)

  • ID: 4457174
  • Report
  • Region: United States
  • 1036 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • Aastrom
  • Arthrex
  • Celling Biosciences
  • Genzyme
  • LifeNet Health
  • Orthofix
  • MORE
General Report Contents
  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
Orthopedic biomaterials are associated with high research and development (R&D) costs, which have subsequently led to premium pricing to recoup these initial costs. This is the case for competitors in the cellular allograft, cell therapy and growth factor segments of the U.S. orthopedic biomaterials market. In particular, orthopedic growth factors have had relatively high average selling prices (ASP) since their introduction to the market due to the high costs of recombinant growth factor technologies.

The high R&D costs associated with the growth factor segment provide entry barriers against potential competitors. Currently there are only two growth factor BMP-2 products in the United States. Since they’re both used in different indications, there is a lack of direct competition, allowing companies such as Medtronic to charge a premium for the Spine indication and recover the large initial costs associated with R&D. The commoditized nature in some parts of the market, such as the allograft and DBM segments, which is due to the lack of product differentiation, has limited growth.

The market is being driven by more competitors venturing outside their traditional space to tap into the high growth segments where they can charge a premium. These segments may include the cell therapy and cellular allograft segments, both of which have relatively high ASP.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aastrom
  • Arthrex
  • Celling Biosciences
  • Genzyme
  • LifeNet Health
  • Orthofix
  • MORE
Table of Contents I
List of Figures Viii
List of Charts Xiii
Executive Summary
U.S. Orthopedic Biomaterials Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2. U.S. Diagnostic Ophthalmic Device Market Overview
2.1 Introduction
2.1.1 Bone Graft Substitutes
2.1.2 Growth Factors
2.1.3 Orthopedic Stem Cell Therapy
2.1.4 Cell Therapies
2.1.5 Hyaluronic Acid Viscosupplementation
2.1.6 Cartilage Repair
2.1.7 Spinal Machined Bone Allografts
2.2 Market Overview
2.3 Trend Analysis By Segment
2.4 Drivers and Limiters
2.4.1 Market Drivers
2.4.2 Market Limiters
2.5 Competitive Market Share Analysis
2.6 Herfindahl Index

3. Procedure Numbers
3.1 Procedure Definitions
3.2 Bone Graft Procedure Numbers By Type
3.3 Bone Graft Substitute Procedure Numbers
3.3.1 By Material
3.3.2 By Indication
3.4 Growth Factor Bone Graft Procedure Numbers
3.5 Stem Cell Bone Graft Procedure Numbers
3.6 Cell Therapy Treatment Numbers
3.6.1 Overview By Type
3.6.2 Platelet-Rich Treatment Numbers By Indication
3.6.3 Platelet-Rich Treatment Numbers By Indication
3.7 Hyaluronic Acid Treatment Numbers By Type
3.8 Cartilage Repair Procedure Numbers By Type
3.9 Spinal Machined Bone Allograft Procedure Numbers By Approach

4. Orthopedic Bone Graft Substitute Market
4.1 Introduction
4.1.1 Units Per Procedure By Indication
4.2 Market Overview
4.2.1 Bone Graft Substitute Market By Material
4.2.2 Bone Graft Substitute Market By Indication
4.3 Market Analysis and Forecast
4.3.1 Total Orthopedic Bone Graft Substitute Market
4.3.2 Bone Graft Substitute Market By Material
4.3.2.1 Total Allograft Bone Graft Substitute Market
4.3.2.2 Allograft Bone Graft Substitute Market By Indication
4.3.2.2.1 Spine
4.3.2.2.2 Trauma
4.3.2.2.3 Large Joint Reconstruction
4.3.2.2.4 Foot Reconstruction
4.3.2.2.5 Craniomaxillofacial
4.3.2.2.6 Oncology
4.3.2.3 Total Demineralized Bone Matrix Market
4.3.2.4 Demineralized Bone Matrix Market With and Without Carriers
4.3.2.5 Demineralized Bone Matrix Market By Indication
4.3.2.5.1 Spine
4.3.2.5.2 Trauma
4.3.2.5.3 Large Joint Reconstruction
4.3.2.5.4 Foot Reconstruction
4.3.2.5.5 Craniomaxillofacial
4.3.2.5.6 Oncology
4.3.2.6 Total Synthetic Bone Graft Substitute Market
4.3.2.7 Synthetic Bone Graft Substitute Market By Indication
4.3.2.7.1 Spine
4.3.2.7.2 Trauma
4.3.2.7.3 Large Joint Reconstruction
4.3.2.7.4 Foot Reconstruction
4.3.2.7.5 Craniomaxillofacial
4.3.2.7.6 Oncology
4.3.3 Bone Graft Substitute Market By Indication
4.3.3.1 Spine
4.3.3.1.1 Cervical Spine
4.3.3.1.2 Thoracolumbar Spine
4.3.3.2 Trauma
4.3.3.2.1 Non-Union Trauma
4.3.3.2.2 Fresh Fracture Trauma
4.3.3.3 Large Joint Reconstruction
4.3.3.3.1 Hip Large Joint Reconstruction
4.3.3.3.2 Knee Large Joint Reconstruction
4.3.3.4 Foot Reconstruction
4.3.3.5 Craniomaxillofacial
4.3.3.6 Oncology
4.4 Drivers and Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

5. Orthopedic Growth Factor Market
5.1 Introduction
5.2 Market Analysis and Forecast
5.3 Drivers and Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Competitive Market Share Analysis

6. Orthopedic Stem Cell Market Market
6.1 Introduction
6.2 Market Overview
6.3 Market Analysis and Forecast
6.3.1 Total Orthopedic Stem Cell Market
6.3.1.1 Cervical Spine Stem Cell Market
6.3.1.2 Lumbar Spine Stem Cell Market
6.4 Drivers and Limiters
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 Competitive Market Share Analysis

7. Orthopedic Cell Therapy Market
7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
7.3.1 Total Platelet-Rich Plasma Market
7.3.1.1 Soft Tissue Platelet-Rich Plasma Market
7.3.1.2 Orthopedic Platelet-Rich Plasma Market
7.3.1.3 Cardiac Platelet-Rich Plasma Market
7.3.1.4 Spine Platelet-Rich Plasma Market
7.3.1.5 Plastics Platelet-Rich Plasma Market
7.3.2 Total Bone Marrow Concentrate Market
7.3.2.1 Spine Bone Marrow Concentrate Market
7.3.2.2 Trauma Bone Marrow Concentrate Market
7.3.2.3 Soft Tissue Concentrated Bone Marrow Aspirate Market
7.3.2.4 Joint Concentration Bone Marrow Concentrate Market
7.4 Drivers and Limiters
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 Competitive Market Share Analysis

8. Orthopedic Hyaluronic Acid Viscosupplementation Market
8.1 Introduction
8.2 Market Overview
8.3 Market Analysis and Forecast
8.3.1 Total Hyaluronic Acid Viscosupplementation Market
8.3.1.1 Single-Injection Hyaluronic Acid Viscosupplementation Market
8.3.1.2 Three-Injection Hyaluronic Acid Viscosupplementation Market
8.3.1.3 Five-Injection Hyaluronic Acid Viscosupplementation Market
8.4 Drivers and Limiters
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 Competitive Market Share Analysis

9. Orthopedic Cartilage Repair Market
9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
9.3.1 Osteochondral Allograft Market
9.3.2 Meniscal Allograft Market
9.3.3 Autologous Chondrocyte Implantation Market
9.3.4 Particulated Juvenile Allograft Implant Market
9.3.5 Microfracture Adjunct Market
9.4 Drivers and Limiters
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 Competitive Market Share Analysis

10. Spinal Machined Bone Allograft Market
10.1 Introduction
10.2 Market Overview
10.3 Market Analysis and Forecast
10.3.1 Total Spinal Machined Bone Allograft Market
10.3.2 Alif Machined Bone Allograft Market
10.3.2.1 Plif Machined Bone Allograft Market
10.3.2.2 Tlif Machined Bone Allograft Market
10.3.2.3 Cif Machined Bone Allograft Market
10.4 Drivers and Limiters
10.4.1 Market Drivers
10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

Abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surgical
  • Fidia Pharmaceuticals
  • MTF
  • Orthofix
  • Arthrex
  • AlloSource
  • Aastrom
  • Baxter
  • Harvest Technologies
  • Wright Medical
  • Bacterin International
  • Arteriocyte
  • Exactech
  • LifeNet Health
  • Biocomposites
  • Alphatec Spine
  • Celling Biosciences
  • Globus Medical
  • Nuo Therapeutics
  • K2M
Please Note: Not all companies are currently active in every segment or sub-report from this suite.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll